Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells

Journal of Immunology

Volumn 178, Issue 12, 2007, Pages 7849-7858

  Kang, Hee Kap ^a   Liu, Michael ^a   Datta, Syamal K ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; HISTONE H4; HISTONE H4[71-94]; INTERLEUKIN 6; LIGAND; PEPTIDE; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL STIMULATION; CONTROLLED STUDY; DENDRITIC CELL; DRUG MEGADOSE; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY CELL; LOW DRUG DOSE; MOUSE; NEPHRITIS; NONHUMAN; NUCLEOSOME; PHENOTYPE; PLASMA CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGULATORY T LYMPHOCYTE; REMISSION; SPLEEN CELL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 34250162775     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.12.7849     Document Type: Article

References (53)

1. Larche, M., and D. C. Wraith. 2005. Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat. Med. 11: S69-S76.
2. Kaliyaperumal, A., M. A. Michaels, and S. K. Datta. 1999. Antigen-specific therapy of murine lupus nephritis using nuclcosomal peptides: tolerance spreading impairs pathogenic function of autoimmune T and B cells. J. Immunol. 16: 5775-5783.
3. Kang, H. K., M. A. Michaels, B. R. Berner, and S. K. Datta. 2005. Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets. J. Immunol. 174: 3247-3255.
4. Hahn, B. H., R. R. Singh, W. K. Wong, B. P. Tsao, K. Bulpitt, and F. M. Ebling. 2001. Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus. Arthritis Rheum. 44: 432-441.
5. + cells and TGF-β. Proc. Natl. Acad. Sci. USA 103: 8810-8815.
6. Shlomchik, M., M. Mascelli, H. Shan, M. Z. Radic, D. Pisetsky, A. Marshak-Rothstein, and M. Weigert. 1990. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J. Exp. Med. 171: 265-292.
7. Mohan, C. S. Adams, V. Stanik, and S. K. Datta. 1993. Nucleosome: a major immunogen for pathogenic autoantibody-indueing T cells of lupus. J. Exp. Med. 177: 1367-1381.
8. Casciola-Rosen, L. A., G. Anhalt, and A. Rosen. 1994. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179: 1317-1330.
9. Burlingame, R. W., R. L. Rubin, R. S. Balderas, and A. N. Theofilopoulos. 1993. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J. Clin. Invest. 91: 1687-1696.
10. Amoura, Z., J. C. Piette, J. F. Bach, and S. Koutouzov. 1999. The key role of nueleosomes in lupus. Arthritis Rheum. 42: 833-843.
11. Berden, J. H. 1997. Lupus nephritis. Kidney Int. 52: 538-558.
12. Kaliyaperumal, A., C. Mohan, W. Wu, and S. K. Datta. 1996. Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus. J. Exp. Med. 183: 2459-2469.
13. Lu, L., A. Kaliyaperumal, D. T. Boumpas, and S. K. Datta. 1999. Major peptide autoepitopes for nucleosome-specific T cells of human lupus. J. Clin. Invest. 104: 345-355.
14. Shi, Y., A. Kaliyaperumal, L. Lu, S. Southwood, A. Sette, M. A. Michaels, and S. K. Datta. 1998. Promiscuous presentation and recognition of nucleosomal autoepitopes in lupus: rote of autoimmune T cell receptor α chain. J. Exp. Med. 187: 367-378.
15. Kang, H., M. Michaels, and S. Datta. 2002. Low-dose tolerance therapy of lupus with nucleosomal histone peptides. Arthritis Rheum. 46(Suppl. S225): Abstract 526.
16. Riemekasten, G., D. Langnickel, P. Enghard, R. Undeutsch, J. Humrich, F. M. Ebling, B. Hocher, T. Humaljoki, H. Neumayer, G. R. Burmester, et al. 2004. Intravenous injection of a D1 protein of the Smith proteins postpones murine lupus and induces type 1 regulatory T cells. J. Immunol. 173: 5835-5842.
17. + T cells from lupus patients by a promiscuous, protective peptide analog. J. Immunol. 175: 5839-5847.
18. Wu, H. Y., F. J. Ward, and N. A. Staines. 2002. Histone peptide-induced nasal tolerance: suppression of murine lupus. J. Immunol. 169: 1126-1134.
19. Suen, J. L., Y. H. Chuang, B. Y. Tsai, P. M. Yau, and B. L. Chiang. 2004. Treatment of murine lupus using nucleosomal T cell epitopes identified by bone marrow-derived dendritic cells. Arthritis Rheum. 50: 3250-3259.
20. Decker, P., A. Le Moal, J. P. Briand, and S. Muller. 2000. Identification of a minimal T cell epitope recognized by antinucleosome Th cells in the C-terminal region of histone H4. J. Immunol. 165: 654-662.
21. Dresser, D. W. 1962. Specific inhibition of antibody production. II. Paralysis induced in adult mice by small quantities of protein antigen. Immunology 5: 378-388.
22. Mitchison, N. A. 1964. Induction of immunological paralysis in two zones of dosage. Proc. R Soc. Lond. B Biol. Sci. 161: 275-292.
23. Chiller, J. M., G. S. Habicht, and W. O. Weigle. 1971. Kinetic differences in unresponsiveness of thymus and bone marrow cells. Science 171: 813-815.
24. Kretschmer, K., I. Apostolou, D. Hawiger, K. Khazaie, M. C. Nussenzweig, and H. von Boehmer. 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6: 1219-1227.
25. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
26. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189.
27. Eastcott, J. W., R. S. Schwartz, and S. K. Datta. 1983. Genetic analysis of the inheritance of B cell hyperactivity in relation to the development of autoantibodies and glomerulonephritis in NZB x SWR crosses. J. Immunol. 131: 2232-2239.
28. Blanco, P., A. K. Palucka, M. Gill, V. Pascual, and J. Banchereau. 2001. Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus. Science 294: 1540-1543.
29. Datta, S. K., L. Zhang, and L. Xu. 2005. T-helper cell intrinsic defects in lupus that break peripheral tolerance to nuclear autoantigens. J. Mol. Med. 83: 267-278.
30. Kaliyaperumal, A., M. A. Michaels, and S. K. Datta. 2002. Naturally processed chromatin peptides reveal a major autoepitope that primes pathogenic T and B cells of lupus. J. Immunol. 168: 2530-2537.
31. Vremec, D., J. Pooley, H. Hochrein, L. Wu, and K. Shortman. 2000. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164: 2978-2986.
32. Barrat, F. J., T. Meeker, J. Gregorio, J. H. Chan, S. Uematsu, S. Akira, B. Chang, O. Duramad, and R. L. Coffman. 2005. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J. Exp. Med. 202: 1131-1139.
33. Jiang, W., W. J. Swiggard, C. Heufler, M. Peng, A. Mirza, R. M. Steinman, and M. C. Nussenzweig. 1995. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 375: 151-155.
34. + regulatory T cells by targeting of antigens to immature dendritic cells. Blood 101: 4862-4869.
35. Keir, M. E., S. C. Liang, I. Guleria, Y. E. Latchman, A. Qipo, L. A. Albacker, M. Koulmanda, G. J. Freeman, M. H. Sayegh, and A. H. Sharpe. 2006. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 203: 883-895.
36. Weijzen, S., S. C. Meredith, M. P. Velders, A. G. Elmishad, H. Schreiber, and W. M. Kast. 2001. Pharmacokinetic differences between a T cell-tolerizing and a T cell-activating peptide. J. Immunol. 166: 7151-7157.
37. Raimondi, G., I. Zanoni, S. Citterio, P. Ricciardi-Castagnoli, and F. Granucci. 2006. Induction of peripheral T cell tolerance by antigen-presenting B cells. II. Chronic antigen presentation overrules antigen-presenting B cell activation. J. Immunol. 176: 4021-4028.
38. Wu, H. Y., A. Monsonego, and H. L. Weiner. 2006. The mechanism of nasal tolerance in lupus prone mice is T-cell anergy induced by immature B cells that lack B7 expression. J. Autoimmun. 26: 116-126.
39. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
40. - cells to develop suppressive activity: the role of IL-2, TGF-β, and IL-10. J. Immunol. 172: 5213-5221.
41. Fallarino, F., C. Asselin-Paturel, C. Vacea, R. Bianchi, S. Gizzi, M. C. Fioretti, G. Trinchieri, U. Grohmann, and P. Puccetti. 2004. Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement. J. Immunol. 173: 3748-3754.
42. + T cell-mediated suppression by dendritic cells. Science 299: 1033-1036.
43. Wu, X., and S. L. Peng. 2006. Toll-like receptor 9 signaling protects against murine lupus. Arthritis Rheum. 54: 336-342.
44. Mangan, P. R., L. E. Harrington, D. B. O'Quinn, W. S. Helms, D. C. Bullard, C. O. Elson, R. D. Hatton, S. M. Wahl, T. R. Schoeb, and C. T. Weaver. 2006. Transforming growth factor-β induces development of the Th17 lineage. Nature 441: 231-234.
45. Lee, J., W. H. Ho, M. Maruoka, R. T. Corpuz, D. T. Baldwin, J. S. Foster, A. D. Goddard, D. G. Yansura, R. L. Vandlen, W. I. Wood, and A. L. Gurney. 2001. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J. Biol. Chem. 276: 1660-1664.
46. Knoechel, B., J. Lohr, E. Kahn, J. A. Bluestone, and A. K. Abbas. 2005. Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen. J. Exp. Med. 202: 1375-1386.
47. + regulatory T cells by peripheral expansion. J. Immunol. 173: 7259-7268.
48. Apostolou, I., and H. von Boehmer. 2004. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199: 1401-1408.
49. Michaels, M. A., H. K. Kang, A. Kaliyaperumal, E. Satyaraj, Y. Shi, and S. K. Datta. 2005. A defect in deletion of nucleosome-specific autoimmune T cells in lupus-prone thymus: role of thymic dendritic cells. J. Immunol. 175: 5857-5865.
50. Pedotti, R., D. Mitchell, J. Wedemeyer, M. Karpuj, D. Chabas, E. M. Hattab, M. Tsai, S. J. Galli, and L. Steinman. 2001. An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide. Nat. Immunol. 2: 216-222.
51. Ohtsuka, K., J. D. Gray, M. M. Stimmler, B. Toro, and D. A. Horwitz. 1998. Decreased production of TGF-β by lymphocytes from patients with systemic lupus erythematosus. J. Immunol. 160: 2539-2545.
52. Singh, R. R., F. M. Ebling, D. A. Albuquerque, V. Saxena, V. Kumar, E. H. Giannini, T. N. Marion, F. D. Finkelman, and B. H. Hahn. 2002. Induction of autoantibody production is limited in nonautoimmune mice. J. Immunol. 169: 587-594.
53. + T cell suppressors. J. Immunol. 175: 7728-7737.